Ajanta Pharma Ltd AJANTPHARM.NS
₹3,513.60 ₹68.60 (1.99%) 1D
Last Updated: Sep 07, 12:00 AM·NSE
Pricing for IN stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Ajanta Pharma Ltd Stock Halal?
Shariah Compliance Analysis of AJANTPHARM.NS Stock
India Health Care Mid Cap Yes. As of September 2026, Ajanta Pharma Ltd (AJANTPHARM.NS) is classified as HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Ajanta Pharma Ltd passes Musaffa's business and financial screening criteria.
Ajanta Pharma Ltd. is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. The company provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. The company is focused on branded generic businesses across India, Asia, and Africa. The company has a wide range of therapeutic segments, such as cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecology, pediatric and general health products. Its business also consists of two verticals: the United States generics and the institutional business in Africa. Its ophthalmology products include Bimat (anti glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic). Its cardiology products include MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex and Vilatin. Its subsidiaries include Ajanta Pharma (Mauritius) Limited, Ajanta Pharma USA Inc., Ajanta Pharma Philippines Inc., and Ajanta Pharma Nigeria Limited.
AJANTPHARM.NS Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Ajanta Pharma Ltd is classified as halal.
HALAL
Report Source: undefined Quarter Report
Ajanta Pharma Ltd (AJANTPHARM.NS) Chart
Financial Metrics & Statements of Ajanta Pharma Ltd (AJANTPHARM.NS)
FAQ's for Ajanta Pharma Ltd (AJANTPHARM.NS)
- As of September 2026, Ajanta Pharma Ltd AJANTPHARM.NS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Ajanta Pharma Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Ajanta Pharma Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Ajanta Pharma Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Ajanta Pharma Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Ajanta Pharma Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Ajanta Pharma Ltd (AJANTPHARM.NS)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
